Oral Drug S-1 Linked to Longer Survival Than Capecitabine in Metastatic Breast Cancer Study
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
Tag: progression-free survival
Indirect Trial Comparison Suggests Retifanlimab Edges Out Avelumab in Metastatic Merkel Cell Carcinoma
A matching-adjusted indirect comparison of two landmark trials suggests retifanlimab significantly prolongs progression-free survival compared with avelumab in metastatic Merkel ...
Real-World Data Show Trastuzumab Deruxtecan Extends Survival in HER2-Low Metastatic Breast Cancer
A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...
A Simple Blood Protein Could Reveal How Aggressive Advanced Prostate Cancer Will Be
Danish researchers report that elevated serum levels of the macrophage-derived protein soluble CD163 independently predict shorter progression-free survival in metastatic ...
Real-World Data Show Antibody-Drug Conjugate Still Works in Late-Stage Triple-Negative Breast Cancer
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
Scarring Lungs Light Up on PET Scans, Hinting at How Deadly Pulmonary Fibrosis Will Become
New research links metabolic activity measured by FDG-PET/CT in scarred lung tissue to clinical severity and hints at faster disease ...
Adding Bevacizumab to Olaparib Boosts Survival Only in BRCA-Mutated Ovarian Cancer
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
Brain Tumor Study Reveals How Much Surgery Matters in Oligodendroglioma
A 277-patient retrospective cohort study finds that gross total resection independently prolongs progression-free survival in molecularly defined oligodendroglioma without increasing ...
Stem Cell Transplant Deepens Myeloma Response, and a Year of MRD Negativity May Signal Lasting Remission
A real-world study of fifty multiple myeloma patients found that high-dose melphalan with autologous stem cell transplantation doubled complete response ...
PET Scan Data Joins Clinical Factors to Predict Relapse in MALT Lymphoma
Researchers in Wuhan have built a prognostic nomogram that combines FDG PET/CT metabolic imaging with clinical and pathological variables to ...
Adding Immunotherapy to Chemo and Bevacizumab Extends Survival in Recurrent Cervical Cancer
A retrospective Chinese study finds that adding the PD-1 inhibitor tislelizumab to paclitaxel-carboplatin chemotherapy and bevacizumab significantly improves response rates, ...
Persistent Emotional Distress Tracks With Poorer Survival in Lung Cancer Patients Undergoing Neoadjuvant Therapy and Surgery
A multicenter study of 167 lung cancer patients found that persistent emotional distress across neoadjuvant therapy and surgery was independently ...
PD-1/PD-L1 Inhibitors Boost Nasopharyngeal Cancer Outcomes
In the ever-evolving battle against cancer, nasopharyngeal carcinoma (NPC) stands out due to its unique challenges in treatment and management. ...
MCM2 Expression Predicts Type B Thymomas
In a significant advancement for cancer research, a new study has shed light on the prognostic value of MCM2 in ...
POPULAR NEWS
-
Muscovy Duck Genome Assemblies Reveal Parental Allele Regulatory Patterns in Poultry
-
24 Autosomal STR Markers Reveal High Genetic Diversity in Bihar Santhal
-
Portable Disposable Robot Shows Feasibility Across Twenty Peripheral Endovascular Procedures
-
VR Direction Passwords Outperform Numeric Codes in Memorability